Socinski, M. A., Wang, X. F., Baggstrom, M. Q., Gu, L., Stinchcombe, T. E., Edelman, M. J., … Vokes, E. E. (2014). Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial. In Journal of Clinical Oncology (Vol. 32, pp. 8040–8040). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.8040

Socinski, Mark A., Xiaofei F. Wang, Maria Quintos Baggstrom, Lin Gu, Thomas E. Stinchcombe, Martin J. Edelman, Sherman Baker JR, Heather Dorothy Mannuel, Jeffrey Crawford, and Everett E. Vokes. “Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial.” In Journal of Clinical Oncology, 32:8040–8040. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.8040.

Socinski MA, Wang XF, Baggstrom MQ, Gu L, Stinchcombe TE, Edelman MJ, et al. Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 8040–8040.

Socinski, Mark A., et al. “Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 8040–8040. Crossref, doi:10.1200/jco.2014.32.15_suppl.8040.

Socinski MA, Wang XF, Baggstrom MQ, Gu L, Stinchcombe TE, Edelman MJ, Baker JR S, Mannuel HD, Crawford J, Vokes EE. Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 8040–8040.